Zoan Biomed Partnership with the European Maritime Fisheries Fund

In 2019 we launched our partnership with the European Maritime and Fisheries Fund of the European Union, CORAL4HEALTH. A 2-year engagement that initiated with high expectations and acknowledgment of the considerable innovation challenges that lay ahead.

The overall aim of the CORAL4HEALTH project was to commercialise the next generation graft bone substitutes, drawn from a sustainable, ethical and high-quality source of marine coral. The major challenge was the utilization of this important, heavily protected marine resource and demonstrating the ability to supply at scale – without having any environmental impact.

The project has made significant progress in bringing Zoan to industrial scale, building on past work, as well as putting in place the regulatory and quality approvals needed to launch its product onto the market.

The engagement has been an outstanding success and highlights the important role of funding from the EU, in bringing early-stage innovative companies to the market. 

The European Maritime and Fisheries Fund looks to support coastal communities in diversifying their economies and support sustainable maritime related businesses and this is a great example of their goals being met. 

We thank the EU for their support and look to the future with confidence and further opportunities together.

Zoan Biomed Partnership with the European Maritime Fisheries Fund

Latest News

Zoan Biomed featured in Bonezone

Zoan Biomed were delighted to be featured in the August edition of the leading orthopaedic industry magazine, Bonezone, a popular US publication covering the most prominent breakthroughs in Orthopaedics.

Northwell Health USA and Portershed Galway Visit Zoan

We were delighted to have the opportunity to host, Mary Rodgers (CEO, PorterShed Galway) ,
Kevin Beiner (Senior Vice President and Regional Executive Director, Northwell Health) Elaine
Brennan (Executive Director & Chief Commercialization Officer at Northwell Health) Jennifer
Scanlon (AVP Strategic Partnerships at Northwell Health) to our facility last week.

KPMG Global Tech Innovator Finalist

Dublin, June 2022 Zoan Biomed was chosen as one of the finalists in the KPMG Global Tech Innovator series. With 70+ impressive entrants representing the very best innovations in Ireland, the 8 finalists got to present to some of Ireland’s leading business personalities.
The Zoan Biomed innovation was lauded for its uniqueness, impact to industry and sustainability credentials.

Zoan BioMed & CELLINK Sign Co-Development Partnership

Dublin, Boston, Gothenburg – April, 2022—Imagine a future where a bone break can be repaired by 3D-printing bones made from marine coral. That reality may come a lot sooner that one might think, thanks to a truly innovative collaboration agreement between Irish-owned, and Galway-based, Zoan BioMed, and Sweden-based CELLINK (STO: BICO). Uniquely, Zoan BioMed sustainably grows…

Contact Us

To find out more about Zoan BioMed get in touch